Literature DB >> 9670361

A mouse model for latent tuberculosis.

S Phyu1, T Mustafa, T Hofstad, R Nilsen, R Fosse, G Bjune.   

Abstract

The aim of the study was to establish a reproducible murine model for latent tuberculosis. We propose an operational definition of latent murine tuberculosis as a stable Mycobacterium-tuberculosis count in lungs and spleens without clinical signs or obvious histopathological changes in the lungs over a long period of time and without spontaneous reactivation of disease. B6D2F1Bom mice were inoculated with a wide range of Mycobacterium tuberculosis doses intraperitoneally or intravenously and followed for a long period to determine suitable conditions to produce latent infection. No anti-tuberculosis drug treatment was used. Microbiological and histopathological studies were carried out. Corticosterone challenge was used to reactivate the latent infection. Mice infected with 4 x 10(4) and 4 x 10(5) bacilli i.p. were followed up to 107 weeks without spontaneous reactivation. The present model is discussed in comparison with previous latent tuberculosis mouse models as well as the possible mechanisms of shift to stationary phase from multiplying bacilli.

Entities:  

Mesh:

Year:  1998        PMID: 9670361     DOI: 10.1080/003655498750002321

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.

Authors:  F Abebe; T Mustafa; A H Nerland; G A Bjune
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis.

Authors:  B M Saunders; A A Frank; I M Orme
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Reactivation of latent tuberculosis by an inhibitor of inducible nitric oxide synthase in an aerosol murine model.

Authors:  Tania Botha; Bernhard Ryffel
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

5.  Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis?

Authors:  T Mustafa; S Phyu; R Nilsen; G Bjune; R Jonsson
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

6.  Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytes.

Authors:  P Seiler; R A Schwendener; S Bandermann; V Brinkmann; L Grode; S H Kaufmann; P Aichele
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice.

Authors:  Sergey Biketov; Vasilii Potapov; Elena Ganina; Katrina Downing; Bavesh D Kana; Arseny Kaprelyants
Journal:  BMC Infect Dis       Date:  2007-12-17       Impact factor: 3.090

8.  Models of latent tuberculosis: their salient features, limitations, and development.

Authors:  Kamlesh Patel; Sarbjit Singh Jhamb; Prati Pal Singh
Journal:  J Lab Physicians       Date:  2011-07

Review 9.  Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens.

Authors:  Yamilé López Hernández; Daniel Yero; Juan M Pinos-Rodríguez; Isidre Gibert
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

10.  The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology.

Authors:  Lisa Heitmann; Mahin Abad Dar; Tanja Schreiber; Hanna Erdmann; Jochen Behrends; Andrew N J Mckenzie; Frank Brombacher; Stefan Ehlers; Christoph Hölscher
Journal:  J Pathol       Date:  2014-08-06       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.